(USD) | Dec 2023 | Q/Q |
---|---|---|
Revenue | 116.5MM | - |
Gross Profit | 101.7MM | - |
Cost Of Revenue | 14.8MM | - |
Operating Income | 91.7MM | -7102% |
Operating Expenses | 10MM | - |
Net Income | 72.3MM | -18483% |
R&D | 2.6MM | -28% |
G&A | 7.4MM | +23% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
If you want to compound wealth in the stock market, you can do so by buying an index fund. But in our experience...
In the latest trading session, Siga Technologies Inc. (SIGA) closed at $8.34, marking a +1.34% move from the previous day.
Siga Technologies Inc. (SIGA) reachead $8.88 at the closing of the latest trading day, reflecting a +0.79% change compared to its last close.
SIGA, SEIC and NTRS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on April 12, 2024.
ZUO, INTZ, SIGA, ENVB and NTRS have been added to the Zacks Rank #1 (Strong Buy) List on April 12, 2024.
SIGA and AZZ made it to the Zacks Rank #1 (Strong Buy) value stocks list on April 12, 2024.
DELL, AGRO and SIGA made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on April 10, 2023.
HITI, MPC and SIGA made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on April 2, 2023.
CXDO, HITI, SIGA, CPG and CTKB have been added to the Zacks Rank #1 (Strong Buy) List on April 2, 2023.
NEW YORK, April 01, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on health security and infectious disease, announced today that it entered into an amendment to its international promotion agreement with Meridian Medical Technologies, Inc. (Meridian). Effective June 1, SIGA will drive international promotion activities for oral TPOXX® while maintaining its contractual relationship with Meridian to maintain continuity for key c